Stevens-Johnson Syndrome in a Patient With Recent SARS-CoV-2 Infection and Ciprofloxacin Administration.
| Autor: | Skafida E; Internal Medicine, General Hospital of Syros, Ermoupoli, GRC., Giannas R; Internal Medicine, General Hospital of Syros, Ermoupoli, GRC. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Sep 12; Vol. 15 (9), pp. e45099. Date of Electronic Publication: 2023 Sep 12 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.45099 |
| Abstrakt: | Stevens-Johnson syndrome (SJS) is an acute, rare, and potentially life-threatening condition with high morbidity and mortality. It is characterized by a blistering rash and erosions with mucosal involvement, which depending on the extent of the skin area involved may be categorized as epidermal necrolysis, along with systemic symptoms. Symptoms are preceded by the administration of a newly introduced drug in almost 80% of cases and less commonly by infections in genetically predisposed individuals. We report a case of SJS in a female patient secondary to a recent SARS-CoV-2 infection and subsequent ciprofloxacin administration. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Skafida et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|